Sophie C. Frölke

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp et al. · Transplantation · 2021 · 189 citations · Full text

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp et al. · PubMed · 2022 · 121 citations · Full text

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Frölke et al. · The Lancet Infectious Diseases · 2022 · 68 citations · Full text

Vaccinology, Vaccination, Transplantation +11

COVID-19 and dysnatremia: A comparison between COVID-19 and non-COVID-19 respiratory illness

Philip J. G. M. Voets, Sophie C. Frölke, Nils P. J. Vogtländer et al. · SAGE Open Medicine · 2021 · 17 citations · Full text

Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients

Sophie C. Frölke, Pim Bouwmans, A. Lianne Messchendorp et al. · Transplantation Direct · 2022 · 17 citations · Full text